BFM
ORGO icon

Boothbay Fund Management’s Organogenesis Holdings ORGO Stock Holding History

Boothbay Fund Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,398
Closed -$69.4K – 2371
2025
Q4 		$69.4K Buy
+13,398
New +$64.9K ﹤0.01% 1789
2022
Q2 		– Sell
-14,881
Closed -$113K – 2557
2022
Q1 		$113K Buy
+14,881
New +$115K ﹤0.01% 2067

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Boothbay Fund Management's ORGO Position: Q1 2026 in Review

Boothbay Fund Management sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 13,398 shares — an estimated $69.4K sold.

Boothbay Fund Management first reported a position in ORGO in Q1 2022 and held it in 2 quarters. The position peaked at $113K in Q1 2022. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Boothbay Fund Management reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 13,398 Organogenesis Holdings shares in Q1 2026, an estimated $69.4K.
  • Boothbay Fund Management first reported a position in Organogenesis Holdings in Q1 2022 and held it in 2 quarters.
  • Boothbay Fund Management's Organogenesis Holdings position peaked at $113K in Q1 2022.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.